BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 22, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Defibrotide regulatory update

Gentium withdrew an NDA for defibrotide because FDA identified numerous issues with the completeness of the dataset for the hepatic veno-occlusive disease (VOD) candidate. Gentium said the agency asked for additional quality...

Read the full 137 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >